Stable and Independent Communication Brain-computer Interfaces
NCT ID: NCT03213561
Last Updated: 2020-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2017-07-11
2019-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Computer Interface Complete locked-in State Communication
NCT02980380
First Study With a Brain Implant to Help Locked-in Patients Communicate at Home
NCT02224469
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis
NCT02266121
Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome
NCT02772302
Invasive Brain-Computer Interfaces for Attention
NCT06940089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable and Independent Communication Brain-computer Interfaces
Each arm will receive the same intervention.
Stable and Independent Brain-computer Interfaces for Communication
The participants will perform an MRI head scan, which the investigators will use to construct 3D head models of participants. The investigators will use these modele to reconstruct the activity of brain sources from EEG signals. The participants will then take part in a series of EEG recording sessions. During the initial "calibration" sessions, the participants will react with real or attempted movements to visual cues. The investigators will use the EEG signals from these sessions to calibrate the text-entry interface used in the validation sessions that follow. During the validation sessions, the participants will control the text-entry interface to write messages using their EEG signals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stable and Independent Brain-computer Interfaces for Communication
The participants will perform an MRI head scan, which the investigators will use to construct 3D head models of participants. The investigators will use these modele to reconstruct the activity of brain sources from EEG signals. The participants will then take part in a series of EEG recording sessions. During the initial "calibration" sessions, the participants will react with real or attempted movements to visual cues. The investigators will use the EEG signals from these sessions to calibrate the text-entry interface used in the validation sessions that follow. During the validation sessions, the participants will control the text-entry interface to write messages using their EEG signals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in French, English, German or Italian
* Good visual acuity
* Older than 18
* Fluent in French, English, German or Italian
* Good visual acuity
* Diagnosed with spinal cord injury, brainstem stroke, spinal stroke, muscular dystrophy or other non-degenerative motor neuron disorders
* Limited or no ability to use both hands - less than grade 4 muscle strength in elbow extension and wrist extension and less than grade 2 strength in finger flexor and abduction on both sides
* Were fluent in French, English, German or Italian before losing the ability to speak
* Enough visual capability to see large letters from a distance of around 50cm according to caretaker's or guardian's opinion
Exclusion Criteria
* Substance or alcohol abuse
* Neurological or psychiatric illness
* History of cranio-facial surgery
* Metallic implants that would prohibit the subject from having a MRI scan
* Medications that may retard motor coordination and cognitive ability (such as sedatives)
* Seizure disorders
* Treated with anti-epileptic medications
* Disabling neurological illness other than tetraplegia or locked-in syndrome
* Disabling psychiatric illness
* History of cranio-facial surgery
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Geneva, Switzerland
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER
University Hospital, Geneva
OTHER
Wyss Center for Bio and Neuroengineering
OTHER
Tomislav Milekovic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomislav Milekovic
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Geneva, Campus Biotech
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-00639
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.